English

Vaxxinity, Inc.

EDGAR

VAXX Annual report amendment (10-K/A) · filed 2024-04-29

14 filing records in this dataset, filed from 2021-10-08 to 2024-04-29. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

50 thousand USD

2022 Q2 · USD

Exact inputs and evidence

Revenue: 50000 USD Source

Operating margin

-34,448%

2022 Q2 · %

Exact inputs and evidence

Operating Income: -17224000 USD Source
Revenue: 50000 USD Source

Operating cash flow

-10.5 million USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -30051000 USD Source
Operating Cash Flow: -19514000 USD Source

Free cash flow

-11.1 million USD

2022 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -30051000 USD Source
Operating Cash Flow: -19514000 USD Source
Capital Expenditure: 1252000 USD Source
Capital Expenditure: 713000 USD Source

Cash and cash equivalents: 4.9 million USD 2023-12-31 Source
Exact value

4900000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-56.9 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Net income: -18400000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -13977000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -13145000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -56900000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -45500000 USD · 2023-01-01 – 2023-09-30 Source

Operating cash flow

-57.2 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Operating cash flow: -20100000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -32200000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -20100000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -45400000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -32200000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -57200000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -45400000 USD · 2023-01-01 – 2023-09-30 Source

Capital expenditure

803 thousand USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Capital expenditure: 172000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 262000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 172000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 389000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 262000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 803000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 389000 USD · 2023-01-01 – 2023-09-30 Source

Free cash flow

-58 million USD

2023-01-01 – 2023-12-31

Exact inputs and evidence

Operating cash flow: -20100000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -32200000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -20100000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -45400000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -32200000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -57200000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -45400000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 172000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 262000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 172000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 389000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 262000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 803000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 389000 USD · 2023-01-01 – 2023-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-04-29.

Financial data available through: 2022-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2022-12-31
Operating income: 3 of 11 periods available· newest 2022-12-31
Net income: 3 of 11 periods available· newest 2022-12-31
Operating cash flow: 3 of 11 periods available· newest 2022-12-31
Capital expenditure: 3 of 11 periods available· newest 2022-12-31
Total assets: 3 of 11 periods available· newest 2022-12-31
Total liabilities: 3 of 11 periods available· newest 2022-12-31
Current assets: 3 of 11 periods available· newest 2022-12-31
Current liabilities: 3 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-100%

Prior period

USD 66,000

2021-01-01 – 2021-12-31
Current period

USD 0

2022-01-01 – 2022-12-31

Exact inputs and evidence

0 − 66000 = -66000 USD

66000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
0 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Year-over-year change in Revenue: -66000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2756882 Filing: 000156276223000132 Input fundies:Revenue: 66000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2757283 Filing: 000156276223000132
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 61.95 million

Prior period

−USD 137.18 million

2021-01-01 – 2021-12-31
Current period

−USD 75.22 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-75222000 − -137175000 = 61953000 USD

-137175000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-75222000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Year-over-year change in Net income: 61953000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -75222000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1948851 Filing: 000156276224000071 Input fundies:NetIncome: -137175000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2951026 Filing: 000156276223000132
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 25.06 million

Prior period

−USD 80.99 million

2021-01-01 – 2021-12-31
Current period

−USD 55.93 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-55928000 − -80990000 = 25062000 USD

-80990000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-55928000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Year-over-year change in Operating cash flow: 25062000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -55928000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1960100 Filing: 000156276224000071 Input fundies:OperatingCashFlow: -80990000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2966581 Filing: 000156276223000132
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+41.6%

Prior period

USD 1.32 million

2021-01-01 – 2021-12-31
Current period

USD 1.87 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

1866000 − 1318000 = 548000 USD

1318000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
1866000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Year-over-year change in Capital expenditure: 548000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1866000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1962891 Filing: 000156276224000071 Input fundies:CapitalExpenditure: 1318000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2969351 Filing: 000156276223000132
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 0
Cost of revenue USD 0
Operating expenses USD 75.98 million
Other operating costs Derived USD 0
Operating income −USD 75.98 million
Tax, interest and other Derived −USD 757,000
Net income −USD 75.22 million

Cash

Operating cash flow −USD 55.93 million
Capital expenditure USD 1.87 million
Free cash flow Derived −USD 57.79 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 5,896% of revenue.
2021 Operating loss: operating costs were 189,608% of revenue.
2022 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	557000	32839000 Derived	-32282000	7675000 Derived	-39957000	-35387000 Derived	Source 2020-01-01 – 2020-12-31: 557000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -32282000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -39957000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -33910000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1477000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	66000	125141000 Derived	-125075000	12100000 Derived	-137175000	-82308000 Derived	Source 2021-01-01 – 2021-12-31: 66000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -125075000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -137175000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -80990000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 1318000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	0	75979000 Derived	-75979000	-757000 Derived	-75222000	-57794000 Derived	Source 2022-01-01 – 2022-12-31: 0 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -75979000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -75222000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -55928000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1866000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	557000	Revenue: 557000 Open source
20212021-12-31	Revenue	66000	Revenue: 66000 Open source
20222022-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 557000 Open source
20212021-12-31	Year over year	-88.2%	Revenue: 66000 Open source Revenue: 557000 Open source
20222022-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 66000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -189,507.6% 2021

Net margin -207,840.9% 2021

Free cash flow margin -124,709.1% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-5,795.7%	Operating Income: -32282000 Open source Revenue: 557000 Open source
20212021-12-31	Operating margin	-189,507.6%	Operating Income: -125075000 Open source Revenue: 66000 Open source
20222022-12-31	Operating margin	Not reported	Operating Income: -75979000 Open source Revenue: 0 Open source
20202020-12-31	Net margin	-7,173.6%	Net Income: -39957000 Open source Revenue: 557000 Open source
20212021-12-31	Net margin	-207,840.9%	Net Income: -137175000 Open source Revenue: 66000 Open source
20222022-12-31	Net margin	Not reported	Net Income: -75222000 Open source Revenue: 0 Open source
20202020-12-31	Free cash flow margin	-6,353.1%	Revenue: 557000 Open source Operating Cash Flow: -33910000 Open source Capital Expenditure: 1477000 Open source
20212021-12-31	Free cash flow margin	-124,709.1%	Revenue: 66000 Open source Operating Cash Flow: -80990000 Open source Capital Expenditure: 1318000 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -55928000 Open source Capital Expenditure: 1866000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -55.9M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-33910000	Operating Cash Flow: -33910000 Open source
20212021-12-31	Operating cash flow	-80990000	Operating Cash Flow: -80990000 Open source
20222022-12-31	Operating cash flow	-55928000	Operating Cash Flow: -55928000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -57.8M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-35387000	Operating Cash Flow: -33910000 Open source Capital Expenditure: 1477000 Open source
20212021-12-31	Free cash flow	-82308000	Operating Cash Flow: -80990000 Open source Capital Expenditure: 1318000 Open source
20222022-12-31	Free cash flow	-57794000	Operating Cash Flow: -55928000 Open source Capital Expenditure: 1866000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

41.6% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	149.7%	Total Liabilities: 75041000 Open source Total Assets: 50141000 Open source
20212021-12-31	Liabilities / assets	22.8%	Total Liabilities: 38054000 Open source Total Assets: 166673000 Open source
20222022-12-31	Liabilities / assets	41.6%	Total Liabilities: 44222000 Open source Total Assets: 106399000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.03× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	0.91×	Current Assets: 35674000 Open source Current Liabilities: 39358000 Open source
20212021-12-31	Current assets / current liabilities	5.61×	Current Assets: 154301000 Open source Current Liabilities: 27494000 Open source
20222022-12-31	Current assets / current liabilities	3.03×	Current Assets: 93887000 Open source Current Liabilities: 30941000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 39.96 million Exact value Exact value: -39957000 USD 2020-01-01 – 2020-12-31: -39957000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxxinity, Inc. · 2020-12-31 Vaxxinity, Inc. (edgar:1851657) Net Income: -39957000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39957000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276222000139/vaxxq410k.htm#2858717 Filing: 000156276222000139 The citation records this snapshot. The page link may show a newer release later.	−USD 33.91 million Exact value Exact value: -33910000 USD 2020-01-01 – 2020-12-31: -33910000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxxinity, Inc. · 2020-12-31 Vaxxinity, Inc. (edgar:1851657) Operating Cash Flow: -33910000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33910000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276222000139/vaxxq410k.htm#2873677 Filing: 000156276222000139 The citation records this snapshot. The page link may show a newer release later.	USD 1.48 million Exact value Exact value: 1477000 USD 2020-01-01 – 2020-12-31: 1477000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxxinity, Inc. · 2020-12-31 Vaxxinity, Inc. (edgar:1851657) Capital Expenditure: 1477000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1477000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276222000139/vaxxq410k.htm#2874749 Filing: 000156276222000139 The citation records this snapshot. The page link may show a newer release later.	−USD 35.39 million Calculation and evidence -33910000 − 1477000 USD Exact free cash flow: -35387000 USD 2020-01-01 – 2020-12-31: -33910000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1477000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxxinity, Inc. · 2020-12-31 Vaxxinity, Inc. (edgar:1851657) Free cash flow: -35387000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33910000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276222000139/vaxxq410k.htm#2873677 Filing: 000156276222000139 Input fundies:CapitalExpenditure: 1477000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276222000139/vaxxq410k.htm#2874749 Filing: 000156276222000139 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 137.18 million Exact value Exact value: -137175000 USD 2021-01-01 – 2021-12-31: -137175000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxxinity, Inc. · 2021-12-31 Vaxxinity, Inc. (edgar:1851657) Net Income: -137175000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -137175000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2951026 Filing: 000156276223000132 The citation records this snapshot. The page link may show a newer release later.	−USD 80.99 million Exact value Exact value: -80990000 USD 2021-01-01 – 2021-12-31: -80990000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxxinity, Inc. · 2021-12-31 Vaxxinity, Inc. (edgar:1851657) Operating Cash Flow: -80990000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -80990000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2966581 Filing: 000156276223000132 The citation records this snapshot. The page link may show a newer release later.	USD 1.32 million Exact value Exact value: 1318000 USD 2021-01-01 – 2021-12-31: 1318000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxxinity, Inc. · 2021-12-31 Vaxxinity, Inc. (edgar:1851657) Capital Expenditure: 1318000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1318000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2969351 Filing: 000156276223000132 The citation records this snapshot. The page link may show a newer release later.	−USD 82.31 million Calculation and evidence -80990000 − 1318000 USD Exact free cash flow: -82308000 USD 2021-01-01 – 2021-12-31: -80990000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 1318000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxxinity, Inc. · 2021-12-31 Vaxxinity, Inc. (edgar:1851657) Free cash flow: -82308000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -80990000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2966581 Filing: 000156276223000132 Input fundies:CapitalExpenditure: 1318000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276223000132/vaxxq410k.htm#2969351 Filing: 000156276223000132 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 75.22 million Exact value Exact value: -75222000 USD 2022-01-01 – 2022-12-31: -75222000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Net Income: -75222000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -75222000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1948851 Filing: 000156276224000071 The citation records this snapshot. The page link may show a newer release later.	−USD 55.93 million Exact value Exact value: -55928000 USD 2022-01-01 – 2022-12-31: -55928000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Operating Cash Flow: -55928000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -55928000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1960100 Filing: 000156276224000071 The citation records this snapshot. The page link may show a newer release later.	USD 1.87 million Exact value Exact value: 1866000 USD 2022-01-01 – 2022-12-31: 1866000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Capital Expenditure: 1866000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1866000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1962891 Filing: 000156276224000071 The citation records this snapshot. The page link may show a newer release later.	−USD 57.79 million Calculation and evidence -55928000 − 1866000 USD Exact free cash flow: -57794000 USD 2022-01-01 – 2022-12-31: -55928000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1866000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Vaxxinity, Inc. · 2022-12-31 Vaxxinity, Inc. (edgar:1851657) Free cash flow: -57794000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-10T05:24:46Z Snapshot: dac3cb0f471f0ac0a4e235ab8ea5348613eaa59be4033e603252cf533a72b7b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1851657?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -55928000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1960100 Filing: 000156276224000071 Input fundies:CapitalExpenditure: 1866000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1851657/000156276224000071/vaxxq410k.htm#1962891 Filing: 000156276224000071 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

14 filings · 713 latest values · 713 originally reported values

Dataset published 2026-11-10. Source filing dates and reporting periods are shown separately.

Identifiers: 0001851657, 1851657, VAXX, edgar:1851657

Also known as VAXXINITY, INC., Vaxxinity, Inc.

Vaxxinity, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation